Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biotalys NV (BTLS)
Biotalys NV stock price live, this page displays EBR BTLS stock exchange data. View the BTLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biotalys NV real time stock price chart below.
What Is the Biotalys NV Stock Price Today?
The Biotalys NV stock price today is 5.00.
What Is the Stock Symbol for Biotalys NV?
The stock symbol for Biotalys NV is ""BTLS.""
What Stock Exchange Does Biotalys NV Trade On?
Biotalys NV is listed and trades on the Brussels stock exchange.
Is Biotalys NV a Good Stock to Buy?
Determining whether Biotalys NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTLS quote. (ISIN: BE0974386188)
What Is the Biotalys NV Stock Price Today?
The Biotalys NV stock price today is 5.00.
What Is the Stock Symbol for Biotalys NV?
The stock symbol for Biotalys NV is ""BTLS.""
What Stock Exchange Does Biotalys NV Trade On?
Biotalys NV is listed and trades on the Brussels stock exchange.
Is Biotalys NV a Good Stock to Buy?
Determining whether Biotalys NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTLS quote. (ISIN: BE0974386188)
Brussels
Currency in EUR
5.00
+0.12(+2.46%)
Closed·
Fair Value
An estimate of a Biotalys NV's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.93
5.04
52 wk Range
2.51
5.50
BTLS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BTLS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Biotalys NV's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.935.04
52 wk Range
2.515.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BTLS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Biotalys NV's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
6.65
Upside
+33.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Biotalys NV receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Biotalys NV Company Profile
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
Compare BTLS to Peers and Sector
Metrics to compare | BTLS | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipBTLSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.2x | −3.2x | 2.7x | |
PEG Ratio | −0.37 | 0.00 | 0.00 | |
Price/Book | 6.8x | 0.9x | 1.6x | |
Price / LTM Sales | - | 0.7x | 1.3x | |
Upside (Analyst Target) | 31.9% | 49.3% | 18.5% | |
Fair Value Upside | Unlock | 21.3% | 0.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 6.65
(+33.00% Upside)
Earnings
Latest Release
Mar 18, 2025
EPS / Forecast
-0.20 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Biotalys NV Trade On?
Biotalys NV is listed and trades on the Brussels Stock Exchange stock exchange.
What Is the Stock Symbol for Biotalys NV?
The stock symbol for Biotalys NV is "BTLS."
What Is the Biotalys NV Market Cap?
As of today, Biotalys NV market cap is 182.85M.
What Is Biotalys NV's Earnings Per Share (TTM)?
The Biotalys NV EPS (TTM) is -0.40.
From a Technical Analysis Perspective, Is BTLS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Biotalys NV Stock Split?
Biotalys NV has split 0 times.
How Many Employees Does Biotalys NV Have?
Biotalys NV has 63 employees.
What is the current trading status of Biotalys NV (BTLS)?
As of 23 Jul 2025, Biotalys NV (BTLS) is trading at a price of 5.00, with a previous close of 4.88. The stock has fluctuated within a day range of 4.93 to 5.04, while its 52-week range spans from 2.51 to 5.50.
What Is Biotalys NV (BTLS) Price Target According to Analysts?
The average 12-month price target for Biotalys NV is EUR6.65, with a high estimate of EUR7.2 and a low estimate of EUR6.1. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +33.00% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.